Indalo Therapeutics

Indalo Therapeutics develops novel integrin antagonists therapies for the treatment of fibrotic diseases.

Business Model:

Revenue: $5M

Employees: 11-50

Rankings

Detailed Indalo Therapeutics Information

Geographic Data

Indalo Therapeutics headquarters map

Address: 400 Technology Square

City: Cambridge

State: MA

Zip: 02139

Country: US

Financial Info

Stage:

series unknown

Raised Last:

$9M

Raised Total:

$10M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Indalo Therapeutics develops novel integrin antagonists therapies for the treatment of fibrotic diseases.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
4/2013 Seed Round 1 - BioGenerator
BioGenerator
6/2017 Equity $9M BioGenerator
Missouri Technology Corporation
iSelect Fund
8/2017 Venture Round 4 $9M Argonautic Ventures
Atlas Venture
Cultivation Capital
F-Prime Capital
Argonautic Ventures
Atlas Venture
Cultivation Capital
F-Prime Capital
9/2015 Equity $100k
10/2015 Seed Round $800k
12/2014 Equity $595.6k
4/2013 Seed Round 1 - BioGenerator
BioGenerator
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research